April 28, 2021
Brett King, MD, PhD
JAK inhibitors are going to change the way we think about refractory disease, says Brett King, MD. He addresses the significant increase in study of these agents and the many potential uses for refractory diseases like alopecia, atopic dermatitis, vitiligo, psoriasis, and more.
View More
Practical Dermatology's coverage of the AAD VMX 2021 is not endorsed by or affiliated with the American Academy of Dermatology (AAD).